Detalhe da pesquisa
1.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
Immunity
; 49(6): 1077-1089.e5, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552020
2.
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Gastroenterology
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490347
3.
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 22(1): 144-153.e2, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391056
4.
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Gastroenterology
; 165(4): 963-975.e5, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499955
5.
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
Dig Dis Sci
; 69(1): 235-245, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015321
6.
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis.
Gut
; 72(11): 2068-2080, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080587
7.
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
Clin Gastroenterol Hepatol
; 21(11): 2908-2917.e10, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280102
8.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 381(13): 1201-1214, 2019 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553833
9.
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
Clin Gastroenterol Hepatol
; 20(3): 578-590.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618023
10.
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
Gastroenterology
; 160(3): 809-822.e7, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160965
11.
Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
PLoS Genet
; 15(5): e1008190, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31145742
12.
Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease.
Dis Colon Rectum
; 64(10): 1259-1266, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516445
13.
Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosis.
Colorectal Dis
; 23(9): 2416-2424, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157179
14.
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
Dig Dis Sci
; 66(1): 199-205, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170473
15.
Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.
Mediators Inflamm
; 2021: 5927064, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257516
16.
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
PLoS Genet
; 14(5): e1007329, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795570
17.
Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids.
Int J Mol Sci
; 22(1)2020 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33396621
18.
Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
Int J Mol Sci
; 21(4)2020 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32093254
19.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
; 375(20): 1946-1960, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959607
20.
Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
Gastroenterology
; 155(3): 829-843, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29792883